No abstract available
Publication types
-
Comparative Study
-
Randomized Controlled Trial
MeSH terms
-
Antibodies, Monoclonal, Humanized* / therapeutic use
-
Anticholesteremic Agents / adverse effects
-
Anticholesteremic Agents / therapeutic use
-
Biomarkers / blood
-
Cardiovascular Diseases* / blood
-
Cardiovascular Diseases* / epidemiology
-
Dyslipidemias / blood
-
Dyslipidemias / diagnosis
-
Dyslipidemias / drug therapy
-
Dyslipidemias / epidemiology
-
Female
-
Humans
-
Lipoprotein(a)* / blood
-
Male
-
Middle Aged
-
PCSK9 Inhibitors
-
Risk Assessment
-
Risk Factors
-
Time Factors
-
Treatment Outcome
Substances
-
Antibodies, Monoclonal, Humanized
-
Lipoprotein(a)
-
alirocumab
-
Biomarkers
-
PCSK9 Inhibitors
-
Anticholesteremic Agents
-
LPA protein, human